Sudden spike in prices lead to gap in the charts for Caplin point. The stock has quickly covered this gap.
So, i think the correction is over for the time being. Yesterday after filling the gap the stock went up by almost Rs 50 later correcting substantially and closing around 362.
One can buy for a target of Rs 389 to start with keeping 346 as stoploss (on ...
I have a biased view on the stock, this being my first 100x stock.
1. USFDA Inspection due week ending 23 Oct 2016
2. Stock split 5:1 on 18th Oct 2016
3. Q2 results to be published in 1st week of Nov
Technically, it is able to over come resistance of 1364 but facing lot of supply around 1450 levels. I expect the stock to touch new highs in ...